AdaptVac ApS: Financial statements 2025
CVR: 38732730
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
AdaptVac ApS (CVR 38732730) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -3,160,505 and a net result of DKK -7,053,665 compared with DKK 1,714,349 the year before. Equity in the 2025 report amounted to DKK 10,808,696. The solvency ratio was 47%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -3,160,505
- Profit/Loss
- DKK -7,053,665
- Equity
- DKK 10,808,696
- Total Assets
- DKK 22,975,523
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -3.2 mio. | -7.1 mio. | 10.8 mio. | 7 |
| 2024 | - | 8.4 mio. | 1.7 mio. | 17.9 mio. | 6 |
| 2023 | - | 69.2 mio. | 50.9 mio. | 58.6 mio. | 6 |
| 2022 | - | -1.6 mio. | -4.8 mio. | 7.8 mio. | 6 |
| 2021 | - | 1.3 mio. | -1.8 mio. | 12.6 mio. | 5 |
Official annual report
How creditworthy is AdaptVac ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
AdaptVac ApS has published its annual report for 2024. Gross profit came to DKK 8,392,621, and the net result was DKK 1,714,349.
About AdaptVac ApS
AdaptVac ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Willem Adriaan De Jongh and Adam Frederik Sander Bertelsen. The board consists of Morten Agertoug Nielsen (chair), Adam Frederik Sander Bertelsen, Ali El-Salanti and Jacob Hjulmand. The company is owned by EXPRES2ION BIOTECHNOLOGIES ApS and NextGen Vaccines Holding ApS. According to the 2025 annual report, the company had an average of 7 employees. In 2025, the company reported a gross profit of DKK -3,160,505 and a net result of DKK -7,053,665 compared with DKK 1,714,349 the year before. Equity in the 2025 report amounted to DKK 10,808,696.